Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Saved in:
| Title: | Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. |
|---|---|
| Authors: | Desai A; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA., Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Hegde A; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Curigliano G; Department of Oncology and Hemato- Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy., Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Liu SV; Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Halmos B; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA., Groisberg R; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Dragovich T; Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA., Matrana M; Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA., Agarwal N; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chawla S; Sarcoma Oncology Center, Santa Monia, CA, USA., Kato S; Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Morgan G; Department of Oncology, Skåne University Hospital, Lund, Sweden., Kasi PM; Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA., Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Loong HH; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Park H; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA., Choueiri TK; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA, USA., Subbiah IM; Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org. |
| Corporate Authors: | COVID19 and Cancer Clinical Trials Working Group |
| Source: | Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 May; Vol. 18 (5), pp. 320. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33758378 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Desai+A%22">Desai A</searchLink>; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Gainor+JF%22">Gainor JF</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hegde+A%22">Hegde A</searchLink>; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Schram+AM%22">Schram AM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato- Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pal+S%22">Pal S</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+SV%22">Liu SV</searchLink>; Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Halmos+B%22">Halmos B</searchLink>; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA.<br /><searchLink fieldCode="AU" term="%22Groisberg+R%22">Groisberg R</searchLink>; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Grande+E%22">Grande E</searchLink>; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dragovich+T%22">Dragovich T</searchLink>; Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Matrana+M%22">Matrana M</searchLink>; Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Agarwal+N%22">Agarwal N</searchLink>; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Chawla+S%22">Chawla S</searchLink>; Sarcoma Oncology Center, Santa Monia, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kato+S%22">Kato S</searchLink>; Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; Department of Oncology, Skåne University Hospital, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Kasi+PM%22">Kasi PM</searchLink>; Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Solomon+B%22">Solomon B</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Loong+HH%22">Loong HH</searchLink>; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+IM%22">Subbiah IM</searchLink>; Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pemmaraju+N%22">Pemmaraju N</searchLink>; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22COVID19+and+Cancer+Clinical+Trials+Working+Group%22">COVID19 and Cancer Clinical Trials Working Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2021 May; Vol. 18 (5), pp. 320. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33758378 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41571-021-00503-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 320 Titles: – TitleFull: Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Desai A – PersonEntity: Name: NameFull: Gainor JF – PersonEntity: Name: NameFull: Hegde A – PersonEntity: Name: NameFull: Schram AM – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Pal S – PersonEntity: Name: NameFull: Liu SV – PersonEntity: Name: NameFull: Halmos B – PersonEntity: Name: NameFull: Groisberg R – PersonEntity: Name: NameFull: Grande E – PersonEntity: Name: NameFull: Dragovich T – PersonEntity: Name: NameFull: Matrana M – PersonEntity: Name: NameFull: Agarwal N – PersonEntity: Name: NameFull: Chawla S – PersonEntity: Name: NameFull: Kato S – PersonEntity: Name: NameFull: Morgan G – PersonEntity: Name: NameFull: Kasi PM – PersonEntity: Name: NameFull: Solomon B – PersonEntity: Name: NameFull: Loong HH – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Choueiri TK – PersonEntity: Name: NameFull: Subbiah IM – PersonEntity: Name: NameFull: Pemmaraju N – PersonEntity: Name: NameFull: Subbiah V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2021 May Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1759-4782 Numbering: – Type: volume Value: 18 – Type: issue Value: 5 Titles: – TitleFull: Nature reviews. Clinical oncology Type: main |
| ResultId | 1 |